Trial Profile
Multicenter Prospective Trial of Efficacy of Naldemedine for Opioid-Induced Constipation in Patients with Advanced Pancreatic Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2021
Price :
$35
*
At a glance
- Drugs Naldemedine (Primary)
- Indications Constipation
- Focus Therapeutic Use
- 04 Feb 2021 Status changed from recruiting to completed.
- 02 Feb 2018 Status changed from not yet recruiting to recruiting.
- 06 Dec 2017 New trial record